Patents Assigned to Vasomune Therapeutics Inc.
  • Agent for promoting angiogenesis and methods and uses thereof
    Patent number: 11384130
    Abstract: The present disclosure relates to compounds of Formula (I) which are multimeric forms of a monomeric binding peptide linearly bonded to PEG moieties to form the multimers. The multimeric forms stimulate angiogenesis and promote wound healing. The disclosure also includes pharmaceutical compositions comprising the multimers, including compositions suitable for topical or systemic administration.
    Type: Grant
    Filed: January 11, 2018
    Date of Patent: July 12, 2022
    Assignees: Vasomune Therapeutics Inc., Sunnybrook Research Institute
    Inventors: Daniel Dumont, Paul van Slyke, David Tumelty, Kenneth Sokoll, Jason Moss